Ingrasciotta, Ylenia
 Distribuzione geografica
Continente #
NA - Nord America 974
EU - Europa 906
AS - Asia 385
SA - Sud America 2
AF - Africa 1
Totale 2.268
Nazione #
US - Stati Uniti d'America 971
IE - Irlanda 321
SE - Svezia 245
IT - Italia 155
CN - Cina 129
SG - Singapore 119
VN - Vietnam 106
PL - Polonia 66
DE - Germania 47
FI - Finlandia 18
RO - Romania 15
IN - India 14
BE - Belgio 10
NL - Olanda 7
ID - Indonesia 6
GB - Regno Unito 5
FR - Francia 4
UA - Ucraina 4
IR - Iran 3
BO - Bolivia 2
CA - Canada 2
CZ - Repubblica Ceca 2
ES - Italia 2
HK - Hong Kong 2
LT - Lituania 2
CH - Svizzera 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.268
Città #
Chandler 324
Dublin 321
Nyköping 140
Ashburn 109
Dong Ket 106
Singapore 93
Messina 72
Warsaw 66
Princeton 51
Medford 42
Beijing 33
Ann Arbor 32
Bremen 30
Des Moines 25
Jacksonville 17
New York 17
Boardman 15
Focsani 15
Rome 13
Los Angeles 11
Washington 11
Brussels 10
Cambridge 10
Dearborn 10
Frankfurt am Main 10
Helsinki 9
Tianjin 9
Wilmington 9
Falls Church 8
Milan 8
Pune 7
Jakarta 6
Ningbo 6
Caltagirone 5
Jinan 5
Shenyang 5
Guangzhou 4
Nanjing 4
Seattle 4
Taizhou 4
Haikou 3
Hyderabad 3
Jiaxing 3
Lancaster 3
Nanchang 3
Redwood City 3
Salerno 3
Zhengzhou 3
Amsterdam 2
Breganze 2
Brno 2
Catania 2
Chengdu 2
Erbè 2
Fairfield 2
Fremont 2
Fuzhou 2
Heidelberg 2
Hong Kong 2
Houston 2
La Paz 2
Lanzhou 2
Misterbianco 2
Nuremberg 2
Palermo 2
San Mateo 2
Venaria Reale 2
Wuhan 2
Alexandria 1
Amman 1
Aversa 1
Bari 1
Cairo 1
Changsha 1
College Station 1
Cormano 1
Cosenza 1
Dalian 1
Durham 1
Gioia del Colle 1
Hamburg 1
Hangzhou 1
Hebei 1
Hefei 1
Kiev 1
Kingston 1
Langfang 1
Lappeenranta 1
Liverpool 1
London 1
Lviv 1
Madrid 1
Mumbai 1
Munich 1
Mykolayiv 1
Newark 1
Ningde 1
Ottawa 1
Pavia 1
Poltava 1
Totale 1.772
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 153
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 108
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 92
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 82
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 76
Psoriasis and psoriasiform reactions secondary to Immune Checkpoint Inhibitors 73
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 73
Analgesic drug use in elderly persons: A population-based study in Southern Italy 69
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 69
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 60
Medication is an additional source of phosphate intake in chronic kidney disease patients 58
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 57
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 57
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 54
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 54
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 51
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 51
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 51
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 49
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 45
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 44
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 43
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 43
Recent advances in the management of chemotherapy-induced neutropenia: Biosimilar granulocyte colony-stimulating factor use in Italy 43
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 43
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 43
Biosimilars in Italy: What do real-world data reveal? 43
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 42
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy 41
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0) 41
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 40
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 39
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies 38
null 37
Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments 37
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 36
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 32
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials 32
null 28
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. 27
The advent of biosimilars for the treatment of diabetes: current status and future directions 27
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 25
null 24
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. 23
null 19
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 19
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo 18
null 18
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients 18
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 17
null 17
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context 10
Hidradenitis suppurativa and psoriasis: the odd couple 7
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review 6
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 5
Totale 2.407
Categoria #
all - tutte 13.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 3 4 2 22 10 44
2020/2021355 6 8 50 42 30 10 19 20 34 28 1 107
2021/2022380 2 23 2 4 16 8 46 5 24 83 33 134
2022/2023945 71 107 37 89 79 94 14 37 378 5 24 10
2023/2024292 17 30 27 31 30 93 15 5 3 14 1 26
2024/2025224 26 14 19 63 56 44 2 0 0 0 0 0
Totale 2.407